Subscribe To
Why shares of fresenius medical care were dropping on wednesday
Novo Nordisk ended a phase 3 trial early for Ozempic for preventing kidney disease because the trial wa...
October 11, 2023, 12:18 pm
Pmv pharmaceuticals to present updated phase 1 data on pc14586 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics and host a kol webinar
PRINCETON, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery an...
October 11, 2023, 12:00 pm
Presentations at idweek 2023 highlight potentially differentiated immunogenicity of gritstone bio’s next generation covid-19 vaccine
— High neutralizing antibody (nAb) responses sustained through at least 12 months, highlighting potential for durable clinical protection — — T ...
October 11, 2023, 11:10 am
Immunic presents data from phase 2 study of vidofludimus calcium in relapsing-remitting ms
Immunic Inc (NASDAQ:IMUX) announced that data from its phase 2 EMPhASIS trial of nuclear receptor-relat...
October 11, 2023, 10:11 am
Anaptys to present phase 1 data on anb032, its btla agonist antibody, at the 32nd eadv congress
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...
October 11, 2023, 9:15 am
Relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023
Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body weight gain in a mice model ...
October 11, 2023, 8:31 am
Why is tempest therapeutics (tpst) stock up 325% today?
Tempest Therapeutics (NASDAQ: TPST ) stock is taking off on Wednesday as the clinical-stage oncology company prepares to release new study results. A...
October 11, 2023, 7:41 am
Neurocrine's crinecerfont delivered, but the street has been slow to reward the success
Neurocrine Biosciences has reported very positive phase III results for crinecerfont in adult and pedia...
October 11, 2023, 3:44 am
An2 therapeutics to present new data for epetraborole at idweek 2023
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatment...
October 11, 2023, 12:01 am
Hyliion holdings: sell on decision to give up on core electric powertrain business
Market participants have been caught flat-footed by the company's decision to pursue strategic alternatives to its core electric powertrain business a...
October 10, 2023, 10:20 pm
Goldman sachs: wait-and-see approach for the us dollar
Synopsis: Goldman Sachs adopts a cautious stance on the USD, indicating that the market seems to be in a 'wait-and-see' ...
October 10, 2023, 6:57 pm
Eur/usd forex signal: inverted h&s pattern forms
Timeline: 1-2 days. Bearish view Set a sell-stop at 1.0525 and a take-profit at 1.0450. Add a stop-loss at 1.0625. The EUR/USD exchange rate remained ...
October 10, 2023, 6:29 pm
Usd/jpy drifting, eyes fomc minutes
The Japanese yen is drifting on Tuesday. In the North American session, USD/JPY is trading at 148.67, up 0.10%. The Bank of Japan continues to stick t...
October 10, 2023, 5:02 pm
Inovio shares rise after positive fda feedback on rrp treatment candidate
Biotechnology company Inovio saw its shares jump after the US FDA communicated that data from Inovio completed ...
October 10, 2023, 2:47 pm
Down 45%, is intellia a buy?
Intellia has declined over the past year even as its candidates for severe diseases have advanced in clinical studies. The company aims to launch a ...
October 10, 2023, 2:00 pm
Roche's (rhhby) vabysmo positive in late-stage rvo studies
Roche (RHHBY) Vabysmo maintains vision improvements with extended treatment intervals of up to four months in ...
October 10, 2023, 1:32 pm
Enphase (enph) unveils energy system in sweden and denmark
Enphase (ENPH) launches a home energy system in the solar markets of Sweden and Denmark in collaboratio...
October 10, 2023, 12:01 pm
Enphase energy announces conference call to review third quarter 2023 financial results thursday, oct. 26, 2023 at 4:30 p.m. eastern time
FREMONT, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energ...
October 10, 2023, 12:00 pm
Why akero therapeutics stock is crashing today
Akero's experimental NASH drug efruxifermin (EFX) missed its primary endpoint in a phase 2b study. Howe...
October 10, 2023, 11:44 am
Bioatla provides guidance on near-term milestones and plans to announce third quarter 2023 financial results and business update on november 7, 2023
Submitted abstract on CAB-AXL-ADC, BA3011, in non-small cell lung cancer (NSCLC) to the IASLC 2023 North America Conference on Lung Cancer; KOL event ...
October 10, 2023, 11:30 am